{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:17:00Z","timestamp":1788254220722,"version":"build-2803163510"},"reference-count":25,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objective: Hematologic cancer patients are at high risk of developing chronic subdural hematomas (cSDH), and traditional treatment with surgery is potentially risky in this patient population, with associated coagulopathy and thrombocytopenia. Neurointerventional endovascular middle meningeal artery embolization (MMAE) is emerging as a novel minimally invasive treatment method for cSDH, and its efficacy and complication profile has not been evaluated in patients with hematologic cancers. Methods: We conducted a retrospective cohort study of adults with hematologic malignancies and cSDH between 2015 and 2025 and compared the efficacy and safety of treatment with MMAE versus open surgery. Variables were abstracted from the medical records. Primary outcomes were necessity for rescue treatment within 180 days after the index procedure and time to restart systemic cancer therapy among patients whose treatment was held due to subdural hematoma. Inverse probability of treatment weighting (IPTW) was applied using covariate-balancing propensity scores to address confounding by indication. Time-to-event outcomes were analyzed using weighted Cox proportional hazards models and Kaplan\u2013Meier methods. Results: A total of 67 patients with hematologic malignancies and cSDH were included (37 treated with MMAE and 30 with surgical evacuation). After IPTW, baseline covariates were well balanced between groups. MMAE was associated with a significantly lower risk of requiring rescue treatment than surgery (HR, 0.19; 95% CI, 0.05\u20130.81). This association persisted after accounting for the competing risk of death (Fine\u2013Gray subdistribution HR, 0.21; 95% CI, 0.06\u20130.77). Prolonged Activated Partial Thromboplastin Time was associated with a higher risk of requiring rescue treatment. The median time to resume systemic therapy was significantly shorter following MMAE (13.5 days; 95% CI, 9\u201326) than after surgery (27.0 days; 95% CI, 22\u201350) (p = 0.005). Conclusions: In patients with hematologic malignancies and symptomatic cSDH, MMAE was associated with fewer rescue interventions and earlier resumption of systemic therapy compared with surgical evacuation, suggesting that embolization may represent an effective and minimally invasive treatment strategy that preserves continuity of oncologic care in this high-risk population.<\/jats:p>","DOI":"10.3390\/cancers18172824","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:31:13Z","timestamp":1788251473000},"page":"2824","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preserving Continuity of Cancer Therapy in Patients with Hematologic Malignancies and Chronic Subdural Hematomas: Comparative Outcomes of Middle Meningeal Artery Embolization and Surgery"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2775-0157","authenticated-orcid":false,"given":"Esteban","family":"Ramirez-Ferrer","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-3752","authenticated-orcid":false,"given":"Juan P.","family":"Zuluaga-Garcia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5675-2669","authenticated-orcid":false,"given":"Maria A.","family":"Sierra","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad del Rosario, Bogot\u00e1 110221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Danielle","family":"Hammond","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5587-6673","authenticated-orcid":false,"given":"Jeffrey S.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Chibawanye I.","family":"Ene","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Shaan M.","family":"Raza","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Frederick F.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Peter T.","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5580-831X","authenticated-orcid":false,"given":"Stephen R.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Christopher C.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1061","DOI":"10.1016\/j.wneu.2019.07.079","article-title":"Subdural Hematoma in Patients with Hematologic Malignancies: An Outcome Analysis and Examination of Risk Factors of Operative and Nonoperative Management","volume":"130","author":"Wright","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.wneu.2017.06.097","article-title":"Thrombocytopenia and Neurosurgery: A Literature Review","volume":"106","author":"Li","year":"2017","journal-title":"World Neurosurg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3171\/2021.5.JNS21109","article-title":"Middle Meningeal Artery Embolization for Chronic Subdural Hematoma in Cancer Patients with Refractory Thrombocytopenia","volume":"136","author":"Lee","year":"2022","journal-title":"J. Neurosurg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13613-024-01372-5","article-title":"Impact of Critical Illness on Continuation of Anticancer Treatment and Prognosis of Patients with Aggressive Hematological Malignancies","volume":"14","author":"Bredin","year":"2024","journal-title":"Ann. Intensive Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa2401201","article-title":"Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma","volume":"391","author":"Liu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa2313472","article-title":"Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma","volume":"391","author":"Davies","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3174\/ajnr.A6739","article-title":"Middle Meningeal Artery: Anatomy and Variations","volume":"41","author":"Bonasia","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.wneu.2018.05.037","article-title":"Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future","volume":"116","author":"Holl","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJMoa2409845","article-title":"Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma","volume":"392","author":"Fiorella","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1227\/neu.0000000000003722","article-title":"Statins and Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematoma: A Comprehensive Systematic Review and Network Meta-Analysis","volume":"98","author":"Musmar","year":"2025","journal-title":"Neurosurgery"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/STROKEAHA.124.050190","article-title":"Standalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma","volume":"56","author":"Chen","year":"2025","journal-title":"Stroke"},{"key":"ref_12","unstructured":"The University of Texas Medical Branch (2026, August 26). Chronic Subdural Hematoma Treatment with Embolization Versus Surgery Study (CHESS), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06347796."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2025.7.FOCUS25553","article-title":"Chronic Subdural Hematoma Treatment in Oncological Patients: Middle Meningeal Artery Embolization versus Surgical Drainage","volume":"59","author":"Weinberg","year":"2025","journal-title":"Neurosurg. Focus"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards Best Practice When Using Inverse Probability of Treatment Weighting (IPTW) Using the Propensity Score to Estimate Causal Treatment Effects in Observational Studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_16","unstructured":"Posit Team (2025). RStudio: Integrated Development Environment for R, Posit Software, PBC."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00701-020-04398-3","article-title":"Chronic Subdural Hematoma-Incidence, Complications, and Financial Impact","volume":"162","author":"Rauhala","year":"2020","journal-title":"Acta Neurochir."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00277-022-04982-w","article-title":"Clinical Characteristics and Prognostic Factors in Intracranial Hemorrhage Patients with Hematological Diseases","volume":"101","author":"Zhang","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet Transfusion: A Clinical Practice Guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1097\/TA.0000000000003404","article-title":"Paradigms in Chronic Subdural Hematoma Pathophysiology: Current Treatments and New Directions","volume":"91","author":"Bounajem","year":"2021","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/neuros\/nyy521","article-title":"Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Series of 60 Cases","volume":"85","author":"Link","year":"2019","journal-title":"Neurosurgery"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1148\/radiol.2017170053","article-title":"Middle Meningeal Artery Embolization for Chronic Subdural Hematoma","volume":"286","author":"Ban","year":"2018","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/S0140-6736(19)33008-9","article-title":"Four versus Six Cycles of CHOP Chemotherapy in Combination with Six Applications of Rituximab in Patients with Aggressive B-Cell Lymphoma with Favourable Prognosis (FLYER): A Randomised, Phase 3, Non-Inferiority Trial","volume":"394","author":"Poeschel","year":"2019","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","article-title":"Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Pollyea","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.6004\/jnccn.2023.0057","article-title":"NCCN Guidelines\u00ae Insights: B-Cell Lymphomas, Version 6.2023: Featured Updates to the NCCN Guidelines","volume":"21","author":"Zelenetz","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2824\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:38:32Z","timestamp":1788251912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":25,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172824"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172824","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}